NLS Pharmaceutics Ltd. (NASDAQ:NLSP) Short Interest Down 77.6% in April

NLS Pharmaceutics Ltd. (NASDAQ:NLSP) was the recipient of a significant decrease in short interest in April. As of April 15th, there was short interest totalling 75,100 shares, a decrease of 77.6% from the March 31st total of 335,800 shares. Based on an average daily volume of 561,900 shares, the days-to-cover ratio is presently 0.1 days. Approximately 0.3% of the company’s stock are sold short.

NLS Pharmaceutics Stock Performance

NLSP traded up $0.01 on Thursday, reaching $0.13. The company’s stock had a trading volume of 151,396 shares, compared to its average volume of 466,460. The stock has a 50 day moving average of $0.25 and a two-hundred day moving average of $0.44. NLS Pharmaceutics has a fifty-two week low of $0.11 and a fifty-two week high of $1.53.

About NLS Pharmaceutics

NLS Pharmaceutics AG, a clinical-stage biopharmaceutical company, engages in the discovery and development of therapies for patients with rare and complex central nervous system disorders. The company is focusing on the development of treatments for narcolepsy, idiopathic hypersomnia, and other rare sleep disorders, as well as neurodevelopmental disorders, such as attention deficit hyperactivity disorder (ADHD).